Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Pulmatrix (PULM) Shares Outstanding (Diluted Average) (2022 - 2025)

Pulmatrix's Shares Outstanding (Diluted Average) history spans 4 years, with the latest figure at $3.7 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) changed 0.0% year-over-year to $3.7 million; the TTM value through Dec 2025 reached $3.7 million, changed 0.0%, while the annual FY2025 figure was $3.7 million, 0.0% changed from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $3.7 million at Pulmatrix, roughly flat from $3.7 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $3.4 billion in Q4 2022 and bottomed at $3.7 million in Q1 2023.
  • The 4-year median for Shares Outstanding (Diluted Average) is $3.7 million (2023), against an average of $680.6 million.
  • The largest annual shift saw Shares Outstanding (Diluted Average) crashed 99.89% in 2023 before it grew 0.04% in 2024.
  • A 4-year view of Shares Outstanding (Diluted Average) shows it stood at $3.4 billion in 2022, then plummeted by 99.89% to $3.7 million in 2023, then increased by 0.01% to $3.7 million in 2024, then changed by 0.0% to $3.7 million in 2025.
  • Per Business Quant, the three most recent readings for PULM's Shares Outstanding (Diluted Average) are $3.7 million (Q4 2025), $3.7 million (Q3 2025), and $3.7 million (Q2 2025).